Current position:Home >Product >
Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-
Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-(258870-13-2)
- Name: Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-
- Synonyms:(2S,3R)-N-hydroxy-3-(2-methylpropyl)-N'-[(3S)-2-oxo-1-[(3-phenoxyphenyl)methyl]azepan-3-yl]-2-propylbutanediamide;ButanediaMide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)Methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-Methylpropyl)-3-propyl-, (2R,3S)-
- Molecular Formula:C30H41N3O5
- Molecular Weight:523.66364
- CAS Registry Number:258870-13-2
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 957211-19-7/1(2H)-Quinolineethanol, 3,4-dihydro-2-[3-(1,1,2,2-tetrafluoroethoxy)phenyl]-5-[3-(trifluoromethoxy)phenyl]-a-(trifluoromethyl)-, (aS,2R)-
- 1117752-22-3/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6S,7S)-
- 260540-97-4/4-Quinolinamine, 7-chloro-N-[3-[[(1,1-dimethylethyl)amino]methyl]-4-fluorophenyl]-
- 1019839-52-1/Dibenzo[b,f][1,4]thiazepine-8-carboxamide, N-butyl-11-(3-chloro-4-fluorophenyl)-
- 872002-72-7/Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-
- 884339-27-9/N-[4-[(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-7-yl)oxy]phenyl]-N'-[2-methoxy-5-(trifluoromethyl)phenyl]-
- 917369-31-4/N-(4-Methoxyphenyl)-N,2-dimethyl-4-quinazolinamine hydrochloride
- 66774-80-9/Inhoffen Lythgoe Diol Monotosylate
- 66774-71-8/Benzoic acid 7a-methyl-1-(1-methyl-2-oxo-ethyl)-octahydro-inden-4-yl ester
- 886859-14-9/2-Thiophenecarboxamide, 3-[(1R)-1-[2-(difluoromethoxy)-4-[[(1,1-dimethylethyl)amino]methyl]phenyl]ethoxy]-5-imidazo[1,2-a]pyridin-3-yl-
- 321688-88-4/2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime]
- 1239513-63-3/Poloxipan
- 258870-13-2/Butanediamide, N1-[(3S)-hexahydro-2-oxo-1-[(3-phenoxyphenyl)methyl]-1H-azepin-3-yl]-N4-hydroxy-2-(2-methylpropyl)-3-propyl-, (2R,3S)-
- 896720-20-0/1H-Pyrrole-2-carboxamide, 4-[2-[(2-chloro-4-fluorophenyl)amino]-5-methyl-4-pyrimidinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-
- 503555-55-3/PHA 408
- 1195985-43-3/1H-Pyrazole-3-methanamine, 1-(4-bromophenyl)-N-[(1R)-1-(3-chlorophenyl)ethyl]-5-methoxy-α-methyl-, (αR)-
- 1192845-62-7/Benzenepropanoic acid, 3-cyano-4-[(2R)-3-[[1,1-diMethyl-2-(2-naphthalenyl)ethyl]aMino]-2-hydroxypropoxy]-, ethyl ester, (Hydrochloride) (1:1)
- 1192845-63-8/Benzenepropanoic acid, 3-cyano-4-[(2R)-3-[[1,1-diMethyl-2-(2-naphthalenyl)ethyl]aMino]-2-hydroxypropoxy]-, (Hydrochloride) (1:1)
- 300690-71-5/Moclobemide
- 911290-35-2/NW-1772
- 1248541-99-2/1H-Benzimidazole-7-carboxamide, 2-[1,1'-biphenyl]-4-yl-
- 1151513-25-5/1,2,4-Oxadiazole-3-methanamine, 5-[2-(phenylmethyl)-2H-indazol-3-yl]-
- 854758-17-1/A 792611
- 869113-09-7/Umeclidinium bromide
- 847950-09-8/Pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-one, 6-(2,6-dimethylphenyl)-2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-
- 866772-52-3/Benzeneacetamide, α-(cyclopentylmethyl)-N-(5-methoxythiazolo[5,4-b]pyridin-2-yl)-4-[(4-methyl-1-piperazinyl)sulfonyl]-, (αR)-
- 141404-08-2/Cyclohexanone, 3,5-bis[[(1,1-dimethylethyl)dimethylsilyl]oxy]-4-hydroxy-, (3R, 5R)
- 842148-40-7/AKT Kinase Inhibitor
- 1025716-81-7/L-Valine, N-[[8-[(methoxycarbonyl)amino]-3-dibenzofuranyl]sulfonyl]-
- 1044281-58-4/Imidazo[4,5,1-jk][1]benzazepin-2(1H)-one, 4,5,6,7-tetrahydro-7-hydroxy-6-[(1-methylethyl)amino]-, hydrochloride (1:1), (6R,7R)-